Skip to main content
Year archive

MOA Life Plus Co. Ltd. — 2020 filings

All 54 regulatory filings released by MOA Life Plus Co. Ltd. (142760) in 2020, sourced directly from the official regulator.

54 Filings
2020 Period
2020 filings (54)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2020-12-15 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update
2020-11-25 Korean
[기재정정]전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update
2020-11-25 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2020-11-20 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update
2020-11-20 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2020-11-20 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-11-20 Korean
증권발행결과(자율공시)
Share Issue/Capital Change
2020-11-13 Korean
증권발행실적보고서
Share Issue/Capital Change
2020-11-13 Korean
최대주주변경을수반하는주식담보제공계약체결
Major Shareholding Notification
2020-11-13 Korean
최대주주변경
Major Shareholding Notification
2020-11-13 Korean
분기보고서 (2020.09)
Interim / Quarterly Report 9M 2020
2020-11-13 Korean
유상증자또는주식관련사채등의청약결과(자율공시)
Share Issue/Capital Change
2020-11-09 Korean
유상증자최종발행가액확정
Capital/Financing Update
2020-11-03 Korean
[발행조건확정]증권신고서(지분증권)
Share Issue/Capital Change
2020-11-03 Korean
[기재정정]투자설명서
Investor Presentation
2020-11-03 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2020-11-03 Korean
[기재정정]투자설명서
Investor Presentation
2020-11-03 Korean
투자판단관련주요경영사항(뒤센 근디스뒤센 근디스트로피(DMD) 치료제 BLS-M22의 임상 1상 시험 종료)
Legal Proceedings Report
2020-10-29 Korean
투자판단관련주요경영사항(경증 및 중등증 코로나바이러스감염증-19 (COVID-19) 환자를대상으로 BLS-H01 유효성과 안전성을 평가하기 위한 다기관,무작위배정, 이중눈가림, 위약 대조, 평행군, 제 2 상 임상시험 계획신청)
Regulatory Filings
2020-10-20 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2020-10-08 Korean
[발행조건확정]증권신고서(지분증권)
Share Issue/Capital Change
2020-09-25 Korean
유상증자1차발행가액결정
Share Issue/Capital Change
2020-09-25 Korean
투자설명서
Investor Presentation
2020-09-25 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2020-09-25 Korean
권리락(유상증자)
Share Issue/Capital Change
2020-09-25 Korean
[기재정정]증권신고서(지분증권)
Capital/Financing Update
2020-09-10 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change
2020-08-27 Korean
증권신고서(지분증권)
Capital/Financing Update
2020-08-27 Korean
반기보고서 (2020.06)
Interim / Quarterly Report H1 2020
2020-08-14 Korean
전환사채(해외전환사채포함)발행후만기전사채취득(제5회차)
Capital/Financing Update
2020-06-22 Korean
기타경영사항(자율공시)(만기전 취득한 제4회 전환사채 재매각의 건)
Capital/Financing Update
2020-06-18 Korean
분기보고서 (2020.03)
Interim / Quarterly Report Q1 2020
2020-05-15 Korean
기타경영사항(자율공시)(제4회 전환사채 재매각의 건)
Capital/Financing Update
2020-05-14 Korean
전환사채(해외전환사채포함)발행후만기전사채취득(제4회차)
Capital/Financing Update
2020-04-27 Korean
주식교환ㆍ이전결정(종속회사의주요경영사항)
M&A Activity
2020-04-20 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-04-03 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2020-04-01 Korean
타법인주식및출자증권취득결정(종속회사의주요경영사항)
Capital/Financing Update
2020-04-01 Korean
[기재정정]주식매수선택권부여에관한신고
Regulatory Filings
2020-03-31 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change
2020-03-31 Korean
전환청구권행사(제3회차)
Capital/Financing Update
2020-03-31 Korean
[기재정정]전환청구권행사(제3회차)
Share Issue/Capital Change
2020-03-31 Korean
사업보고서 (2019.12)
Annual Report FY 2019
2020-03-30 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update
2020-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2020-03-27 Korean
[기재정정]정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2020-03-27 Korean
감사보고서제출
Audit Report / Information FY 2019
2020-03-18 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2020-03-11 Korean
[기재정정]주주총회소집결의
AGM Information
2020-03-06 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2020-03-05 Korean
주주총회소집결의
AGM Information
2020-03-05 Korean
주주총회집중일개최사유신고
Regulatory Filings
2020-03-05 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports
2020-02-27 Korean